Company news

Alterity Therapeutics Ltd. news in 2024

Alterity Therapeutics Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Alterity Announces Completion of Phase 2 Clinical Trial

December 3, 2024

Appendix 4E Preliminary Final Report

August 29, 2024

Positive Interim Data from ATH434-202 Phase 2 Clinical Trial

July 17, 2024

Alterity Receives a $3.9 million R&D Tax Incentive Refund

March 26, 2024

Alterity Therapeutics Raises $3.25 M AUD in Placement

February 22, 2024

Phase 2 DMC Recommends Continuing Clinical Trial as Planned

February 6, 2024

Decks in 2024